Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hypercholesterolemia”

226 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 226 results

Early research (Phase 1)Not Yet RecruitingNCT07074236
What this trial is testing

Pharmacokinetics and Pharmacodynamics Study

Who this might be right for
Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C
Qilu Pharmaceutical Co., Ltd. 48
Not applicableStudy completedNCT00347217
What this trial is testing

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

Who this might be right for
Hypercholesteremia
AstraZeneca 3,840
Testing effectiveness (Phase 2)Study completedNCT01288469
What this trial is testing

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Sanofi 92
Large-scale testing (Phase 3)Study completedNCT05763875
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.

Who this might be right for
Hypercholesterolemia
Novartis Pharmaceuticals 350
Large-scale testing (Phase 3)Study completedNCT00867165
What this trial is testing

Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)

Who this might be right for
Primary Hypercholesterolemia
Organon and Co 138
Not applicableActive Not RecruitingNCT05399992
What this trial is testing

Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 847
Large-scale testing (Phase 3)Study completedNCT00143663
What this trial is testing

Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol

Who this might be right for
Dyslipidemia
Takeda 361
Testing effectiveness (Phase 2)Study completedNCT00677248
What this trial is testing

LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe

Who this might be right for
Hypercholesterolemia
Karo Bio AB 120
Large-scale testing (Phase 3)Study completedNCT05532800
What this trial is testing

The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hyperlipemia
Shanghai Junshi Bioscience Co., Ltd. 255
Large-scale testing (Phase 3)Study completedNCT00413972
What this trial is testing

Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)

Who this might be right for
Hypercholesterolemia
Organon and Co 392
Post-approval studies (Phase 4)Study completedNCT01551173
What this trial is testing

Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Lipid Metabolism Disorders
Novartis Pharmaceuticals 436
Not applicableEnded earlyNCT05834673
What this trial is testing

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Coronary Heart Disease (CHD)Cerebrovascular Disease+1 more
Monash University 6
Early research (Phase 1)Study completedNCT06184269
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administration of "BR1017-1A" and "BR1017-1B"

Who this might be right for
Essential HypertensionPrimary Hypercholesterolemia
Boryung Pharmaceutical Co., Ltd 58
Not applicableStudy completedNCT05129241
What this trial is testing

Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector

Who this might be right for
Primary Hypercholesterolaemia and Mixed DyslipidaemiaAtherosclerotic Cardiovascular Disease
Sanofi 163
Not applicableStudy completedNCT01930149
What this trial is testing

Promoting Cholesterol Screening

Who this might be right for
Cardiovascular DiseasesLipid TestingPrimary Prevention of Cardiovascular Disease
Northwestern University 480
Post-approval studies (Phase 4)WithdrawnNCT00396240
What this trial is testing

ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals

Who this might be right for
Primary Hypercholesterolaemia
AstraZeneca 1,294
Large-scale testing (Phase 3)Study completedNCT03882892
What this trial is testing

Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)

Who this might be right for
Hypercholesterolemia
Organon and Co 400
Large-scale testing (Phase 3)Study completedNCT00826774
What this trial is testing

Improving the Management of Obesity in Primary Care Practice (The Power-UP Trial)

Who this might be right for
ObesityHypercholesterolemiaMetabolic Syndrome+2 more
University of Pennsylvania 390
Post-approval studies (Phase 4)Study completedNCT00651274
What this trial is testing

Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)

Who this might be right for
AtherosclerosisHypercholesterolemiaCoronary Heart Disease
Organon and Co 144
Large-scale testing (Phase 3)Study completedNCT03413462
What this trial is testing

Efficacy and Safety Study of HS-25 in Chinese Adults With Primary Hypercholesterolemia

Who this might be right for
Primary Hypercholesterolemia
Zhejiang Hisun Pharmaceutical Co. Ltd. 374
Next Page